CoreWeave Inc. (CRWV)

CoreWeave's stock closed at $48.98 on November 9, 2026, up 5.56% on the session, but it remains significant in a downtrend: it is 34.57% below its 50-day average and 45.55% below its 200-day average, and it sits near the bottom of its 52-week range. The gap between the price and the analyst community is the central tension. Wall Street's consensus is Buy, with 32 of 42 analysts rating the stock buy or strong buy and a median target of $126.50, which is 158.3% above the current price. CleaRank's model takes a more cautious view. The stock scores 37 out of 100 and carries a Sell rating, weighed down by the trend, momentum and a loss-making profile. The P/S of 3.56 is 53.2% below the sector median of 7.6, so the discount to peers is a reflection of the losses rather than a sign of cheapness on sales alone.

The stock is below its 50-day and 200-day moving averages ($74.86 and $89.95), and the 50-day average itself sits 16.79% below the 200-day average, a configuration that points to a downtrend that has not yet turned. The 14-day RSI is 36.0, in the bearish zone but not oversold, and the MACD line is negative. The one-month decline of 40.33% and six-month decline of 57.30% show how far the stock has fallen from its recent levels, even though it rose 5.56% in the latest session on volume 12.5% below its average.

Profitability has not caught up: the net profit margin is -25.40%, the operating margin is -1.90%, return on equity is -43.60%, and reported earnings per share over the last 12 months are -$3.69. Debt is high at 10.27 times equity. On the valuation side, the price-to-sales ratio of 3.56 is 53.2% below the sector median of 7.6, which reflects the market's doubts about converting that revenue into profit.

CoreWeave beat the EPS estimate in two of the last four reports, including the August 11, 2026 report, where adjusted EPS of -$1.14 came in 22.45% above the estimate of -$1.47 and the stock rose 19.28% in the next session. The November 10, 2025 report was also a beat, yet the stock fell 16.31% in the first session after it. The May 14, 2025 report missed by 536.36%, and the stock fell 2.51% after it.

Of 42 analysts, 32 rate the stock buy or strong buy, 7 hold it and 3 sell it. Buy ratings numbered 26 of 38 three months ago, so the bullish camp has grown. Citigroup and UBS kept Buy ratings in late 2026, Goldman Sachs upgraded the stock to Buy from Neutral on October 19, 2026, and HSBC kept a Reduce rating. The median target of $126.50 is 158.3% above the price. CleaRank's Sell rating reflects the trend and profitability data, which weigh more heavily than analyst sentiment.

The base case is that the stock stays under its moving averages and trades in a wide range while the market weighs fast revenue growth against continued losses. Revenue grew 112.50% in the latest quarter year on year and analysts expect revenue to rise 150.9% this fiscal year, but they also forecast an EPS loss of $5.19 for 2026 and $4.74 for 2027, so the business has to show narrowing losses before the price can recover its averages. A fall through the 52-week low of $40.58 would extend the slide. Recent analyst actions are mixed: Goldman Sachs upgraded the stock to Buy on October 19, 2026, while HSBC kept its Reduce rating on October 20, 2026. Typical daily moves of about 6.42% mean the stock can swing sharply on any news.

Support: the 52-week low at $40.58 is the nearest level below the price, and a fall would meet it first. It marks the bottom of the stock's one-year range. Resistance: the 20-day exponential average at $58.33 is the nearest level above the price and the first point a rebound would meet. The 50-day simple average at $74.86 comes next, followed by the 200-day simple average at $89.95. The 52-week high at $138.25 is the furthest reference above the price.